NORTHERN TRUST CORP - ENTASIS THERAPEUTICS HLDGS I ownership

ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 23 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q2 2022$51,000
+6.2%
23,160
-9.9%
0.00%
Q1 2022$48,000
-14.3%
25,7130.0%0.00%
Q4 2021$56,000
-34.9%
25,7130.0%0.00%
Q3 2021$86,000
+53.6%
25,713
+23.2%
0.00%
Q2 2021$56,000
+24.4%
20,8740.0%0.00%
Q1 2021$45,000
+55.2%
20,874
+77.0%
0.00%
Q4 2020$29,000
+20.8%
11,7930.0%0.00%
Q3 2020$24,00011,7930.00%
Other shareholders
ENTASIS THERAPEUTICS HLDGS I shareholders Q1 2022
NameSharesValueWeighting ↓
Eventide Asset Management 590,602$1,577,0000.02%
TPG Group Holdings (SBS) Advisors, Inc. 1,020,748$2,725,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 23,058$62,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 110,000$294,0000.01%
Alberta Investment Management Corp 130,000$347,0000.00%
Jaffetilchin Investment Partners, LLC 11,000$29,0000.00%
TWO SIGMA INVESTMENTS, LP 164,229$438,0000.00%
TWO SIGMA ADVISERS, LP 162,942$435,0000.00%
Janney Montgomery Scott LLC 69,487$186,0000.00%
Renaissance Technologies 391,629$1,046,0000.00%
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders